FDA Moves Toward Making Overdose Antidote an Over-the-Counter Drug
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — The U.S. Food and Drug Administration appears poised to approve certain naloxone products for over-the-counter use, a move that would help fight the nation’s opioid epidemic.Naloxone (Narcan, Evzio) can sav…
Learn MorePandemic Saw Big Rise in Deaths to Millennials From Multiple Causes
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — Americans aged 25 to 44 — so-called millennials — are dying at significantly higher rates from three leading killers than similarly aged people just 10 years ago, the latest government data shows.Looking at…
Learn MoreDemand for Mental Health Care Has U.S. Psychologists Overwhelmed: Survey
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — Though the COVID-19 pandemic has eased, a mental health crisis persists, a nationwide survey of U.S. psychologists reveals.And growing demand for help with depression, anxiety and substance use issues means…
Learn MoreHealth Highlights: Nov. 16, 2022
California’s plan to make low-cost insulin could be example for the nation. Earlier this year, the state announced an initiative to bring its own insulin products to market, in response to the steep costs of the lifesaving drug in the United States. R…
Learn MoreWeight-Loss Surgery Slashes Odds for Heart Attack in Very Obese People
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — Getting bariatric surgery may significantly help prevent heart attacks, strokes and angina in very obese people, a new study finds. The study participants were also affected by what’s known as nonalcoholic …
Learn MoreHospitalizations Up Among Infants Younger Than 6 Months During Omicron
TUESDAY, Nov. 15, 2022 (HealthDay News) — During the omicron-predominant period, there was an increase in weekly hospitalizations among infants aged younger than 6 months, but the prevalence of indicators of severe disease did not increase among thes…
Learn MoreFDA Approves Drug Combo for Metastatic Non-Small Cell Lung Cancer
TUESDAY, Nov. 15, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer …
Learn MoreChallenges ID’d for Homeless People With Schizoaffective Disorder
TUESDAY, Nov. 15, 2022 (HealthDay News) — The difficulties in defining schizoaffective disorder, as well as complications associated with managing homeless patients, result in considerable challenges for homeless people with schizoaffective disorder,…
Learn MoreWalmart Offers $3 Billion to Settle Opioid Lawsuits
TUESDAY, Nov. 15, 2022 (HealthDay News) — Another major pharmacy chain has offered billions to settle claims for its role in the opioid epidemic. While saying it would pay out $3.1 billion, Walmart noted in a statement that it “strongly disputes” all…
Learn MoreAmerican Medical Association Pushes for Permanent Use of Standard Time
TUESDAY, Nov. 15, 2022 (HealthDay News) — While the U.S. Senate voted this year to establish a permanent daylight saving time, the American Medical Association (AMA) House of Delegates is instead recommending a permanent change to standard time.Stand…
Learn More